Two Posters Reporting on Cross-Platform Utility of Antigen & Serological QAPs™
- Novel neutralizing anti-S1 SARS-CoV-2 human monoclonal antibody formulation for use as a cross-platform EQA sample and prospective Quality Controls
- Advanced SARS-CoV-2 nucleocapsid protein swab based formulation for use as cross-platform EQA sample and as a prospective Quality Control